52w high/low | ₹670.4 / ₹311.6 |
P/E ratio | 185.38 |
Dividend | 0 |
ROE | 1.6 |
ROCE | 3.18 |
Face value | 1 |
Book value | ₹275.24Cr |
Market capital | ₹8,012.99Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Shilpa Medicare Ltd. , formerly known as Shilpa Antibiotics was incorporated as a private limited company in November 20th, 1987 and has been promoted by Vishnukant C Bhutada and his associates. Shilpa Medicare Limited (SML) is engaged in manufacturing of Active Pharmaceutical Ingredients (API), Formulation and Development service. The company started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The company started commercial production in November 1989. In November 1993, Shilpa Medicare Limited was converted into a Public Limited Company. SML deals in high-quality Active Pharmaceutical Ingredients (APIs), Bulk drug, Intermediates, Formulations and Development service, New Drug Delivery Systems, Peptides / Biotech products and Specialty Chemicals etc. using sophisticated technology meticulously in order to comply with laid down international standards/specifications.